These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

90 related articles for article (PubMed ID: 6600415)

  • 1. Phase II evaluation of vinblastine, methotrexate, and calcium leukovorin rescue in patients with refractory metastatic breast cancer.
    Hortobagyi GN; Yap HY; Blumenschein GR; Buzdar AU; Barnes BC; Legha SS; Wiseman CL
    Cancer; 1983 Mar; 51(5):769-72. PubMed ID: 6600415
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A phase I/II study of vinorelbine, doxorubicin, and methotrexate with leucovorin rescue as first-line treatment for metastatic breast cancer.
    Subramanyan S; Abeloff MD; Bond SE; Davidson NE; Fetting JH; Gordon GB; Kennedy MJ
    Cancer Chemother Pharmacol; 1999; 43(6):497-502. PubMed ID: 10321510
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Methotrexate, vinblastine, doxorubicin, and cisplatin in metastatic breast cancer. A phase II trial of the Hoosier Oncology Group.
    Roth BJ; Sledge GW; Williams SD; Meyer SC; Ansari R; Fisher WB
    Cancer; 1991 Jul; 68(2):248-52. PubMed ID: 2070321
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Vinorelbine is an active antiproliferative agent in pretreated advanced breast cancer patients: a phase II study.
    Gasparini G; Caffo O; Barni S; Frontini L; Testolin A; Guglielmi RB; Ambrosini G
    J Clin Oncol; 1994 Oct; 12(10):2094-101. PubMed ID: 7931479
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Combination chemotherapy with continuous infusion vinblastine and peptichemio for patients with advanced metastatic breast cancer.
    Yap HY; Blumenschein GR; Hortobagyi GN; Buzdar AU; Schell FC; Bodey GP
    Am J Clin Oncol; 1982 Oct; 5(5):511-4. PubMed ID: 7180829
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Mitomycin C and vinblastine chemotherapy for advanced breast cancer.
    Konits PH; Aisner J; van Echo DA; Lichtenfeld K; Wiernik PH
    Cancer; 1981 Sep; 48(6):1295-8. PubMed ID: 6791808
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Carboplatin, methotrexate, and vinblastine in the treatment of patients with advanced urothelial cancer. A phase II trial.
    Boccardo F; Pace M; Guarneri D; Canobbio L; Curotto A; Martorana G
    Cancer; 1994 Apr; 73(7):1932-6. PubMed ID: 8137220
    [TBL] [Abstract][Full Text] [Related]  

  • 8. High-dose methotrexate with leucovorin rescue, vinblastine, and bleomycin with or without tamoxifen in metastatic renal cell carcinoma.
    Bell DR; Aroney RS; Fisher RJ; Levi JA
    Cancer Treat Rep; 1984 Apr; 68(4):587-90. PubMed ID: 6201268
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Phase I trial of paclitaxel, carboplatin, and methotrexate with granulocyte colony-stimulating factor and leucovorin in advanced transitional cell carcinoma.
    Edelman MJ; Meyers FJ; Houston J; Lauder I
    Semin Oncol; 1997 Oct; 24(5 Suppl 15):S15-68-S15-71. PubMed ID: 9346226
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Phase II study of methotrexate, vinblastine, doxorubicin, and cisplatin in patients with squamous cell carcinoma of the upper respiratory or alimentary passages of the head and neck.
    Okuno SH; Mailliard JA; Suman VJ; Edmonson JH; Creagan ET; Nair S; Levitt R; Kugler JW
    Cancer; 2002 Apr; 94(8):2224-31. PubMed ID: 12001121
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Combination chemotherapy with vincristine and methotrexate for advanced refractory breast cancer.
    Yap HY; Blumenschein GR; Tashima CK; Hortobagyi GN; Buzdar AU; Wiseman CL
    Cancer; 1979 Jul; 44(1):32-4. PubMed ID: 222433
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Mitoxantrone, 5-fluorouracil, and high dose leucovorin (NFL) versus intravenous cyclophosphamide, methotrexate, and 5-fluorouracil (CMF) in first-line chemotherapy for patients with metastatic breast carcinoma: a randomized phase II trial.
    Hainsworth JD; Jolivet J; Birch R; Hopkins LG; Greco FA
    Cancer; 1997 Feb; 79(4):740-8. PubMed ID: 9024712
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Vinorelbine and 5-fluorouracil bolus and/or continuous venous infusion plus levofolinic acid as second-line chemotherapy for metastatic breast cancer: an analysis of results in clinical practice of the Gruppo Oncologico Italia Meridionale (GOIM).
    Gebbia V; Caruso M; Borsellino N; Ajello R; Tirrito ML; Chiarenza M; Valenza R; Verderame F; Varvara F; Marrazzo A; Bajardi E; Ferrao F; Bordonaro R; Tralongo P
    Anticancer Res; 2006; 26(4B):3143-50. PubMed ID: 16886648
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Five-day continuous-infusion vinblastine in the treatment of breast cancer.
    Fraschini G; Yap HY; Hortobagyi GN; Buzdar A; Blumenschein G
    Cancer; 1985 Jul; 56(2):225-9. PubMed ID: 4005794
    [TBL] [Abstract][Full Text] [Related]  

  • 15. High-dose methotrexate for advanced breast cancer.
    Yap HY; Blumenschein GR; Yap BS; Hortobagyi GN; Tashima CK; Wang AY; Benjamin RS; Bodey GP
    Cancer Treat Rep; 1979 May; 63(5):757-61. PubMed ID: 313246
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Phase II study with sequential L-asparaginase and methotrexate in advanced refractory breast cancer.
    Yap HY; Benjamin RS; Blumenschein GR; Hortobagyi GN; Tashima CK; Buzdar AU; Bodey GP
    Cancer Treat Rep; 1979 Jan; 63(1):77-83. PubMed ID: 369695
    [TBL] [Abstract][Full Text] [Related]  

  • 17. MVP (mitomycin-C, vinblastine, cisplatin) salvage chemotherapy for relapsed and refractory metastatic breast cancer.
    Hsu C; Yeh KH; Hong RL; Yang CH; Lin MT; Chen YC; Cheng AL
    J Formos Med Assoc; 1997 Mar; 96(3):185-8. PubMed ID: 9080756
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Prolonged disease-free survival in advanced breast cancer treated with "super-CMF" adriamycin: an alternating regimen employing high-dose methotrexate with citrovorum factor rescue.
    Henderson IC; Gelman R; Canellos GP; Frei E
    Cancer Treat Rep; 1981; 65 Suppl 1():67-75. PubMed ID: 6976832
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Combination chemotherapy for metastatic or recurrent carcinoma of the breast--a randomized phase III trial comparing CAF versus VATH versus VATH alternating with CMFVP: Cancer and Leukemia Group B Study 8281.
    Aisner J; Cirrincione C; Perloff M; Perry M; Budman D; Abrams J; Panasci L; Muss H; Citron M; Holland J
    J Clin Oncol; 1995 Jun; 13(6):1443-52. PubMed ID: 7751891
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Vinblastine given as a continuous 5-day infusion in the treatment of refractory advanced breast cancer.
    Yap HY; Blumenschein GR; Keating MJ; Hortobagyi GN; Tashima CK; Loo TL
    Cancer Treat Rep; 1980; 64(2-3):279-83. PubMed ID: 7407762
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.